Education
About Us
Working with TipRanks
Follow Us
Chugai Pharmaceutical Co Ltd (JP:4519)
:4519
RESEARCH TOOLSreports
Total Valuation
Chugai Pharmaceutical Co has a market cap or net worth of $12.59T. The enterprise value is ¥12.08T.
Market Cap$12.59T
Enterprise Value¥12.08T
Share Statistics
Chugai Pharmaceutical Co has 1,679,057,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,679,057,600
Owned by Insiders―
Owned by Institutions0.08%
Financial Efficiency
Chugai Pharmaceutical Co’s return on equity (ROE) is 0.20 and return on invested capital (ROIC) is 20.16%.
Return on Equity (ROE)0.20
Return on Assets (ROA)0.18
Return on Invested Capital (ROIC)20.16%
Return on Capital Employed (ROCE)0.28
Revenue Per Employee232.91M
Profits Per Employee77.06M
Employee Count5,026
Asset Turnover0.53
Inventory Turnover1.41
Valuation Ratios
The current PE Ratio of Chugai Pharmaceutical Co is 29.74. Chugai Pharmaceutical Co’s PEG ratio is 5.10.
PE Ratio29.74
PS Ratio0.00
PB Ratio6.47
Price to Fair Value6.06
Price to FCF34.92
Price to Operating Cash Flow29.69
PEG Ratio5.10
Income Statement
In the last 12 months, Chugai Pharmaceutical Co had revenue of 1.17T and earned 387.32B in profits. Earnings per share was 235.39.
Revenue1.17T
Gross Profit831.20B
Operating Income542.00B
Pretax Income543.03B
Net Income387.32B
EBITDA568.39B
Earnings Per Share (EPS)235.39
Cash Flow
In the last 12 months, operating cash flow was 415.36B and capital expenditures -62.18B, giving a free cash flow of 353.18B billion.
Operating Cash Flow415.36B
Free Cash Flow353.18B
Free Cash Flow per Share210.34
Dividends & Yields
Chugai Pharmaceutical Co pays an annual dividend of ¥75, resulting in a dividend yield of 1.24%
Dividend Per Share¥75
Dividend Yield1.24%
Payout Ratio22.87%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.00
52-Week Price Change55.26%
50-Day Moving Average7.48K
200-Day Moving Average7.07K
Relative Strength Index (RSI)51.67
Average Volume (3m)2.07M
Important Dates
Chugai Pharmaceutical Co upcoming earnings date is Jul 24, 2025, TBA Not Confirmed.
Last Earnings DateApr 24, 2025
Next Earnings DateJul 24, 2025
Ex-Dividend DateJun 27, 2025
Financial Position
Chugai Pharmaceutical Co as a current ratio of 5.53, with Debt / Equity ratio of 0.69%
Current Ratio5.53
Quick Ratio4.70
Debt to Market Cap0.00
Net Debt to EBITDA-0.95
Interest Coverage Ratio-527.75
Taxes
In the past 12 months, Chugai Pharmaceutical Co has paid 155.72B in taxes.
Income Tax155.72B
Effective Tax Rate0.29
Enterprise Valuation
Chugai Pharmaceutical Co EV to EBITDA ratio is 19.31, with an EV/FCF ratio of 27.67.
EV to Sales9.38
EV to EBITDA19.31
EV to Free Cash Flow27.67
EV to Operating Cash Flow24.53
Balance Sheet
Chugai Pharmaceutical Co has $944.55B in cash and marketable securities with ¥13.09B in debt, giving a net cash position of -$931.46B billion.
Cash & Marketable Securities$944.55B
Total Debt¥13.09B
Net Cash-$931.46B
Net Cash Per Share-$554.75
Tangible Book Value Per Share$1.14K
Margins
Gross margin is 70.98%, with operating margin of 46.30%, and net profit margin of 33.09%.
Gross Margin70.98%
Operating Margin46.30%
Pretax Margin46.39%
Net Profit Margin33.09%
EBITDA Margin48.55%
EBIT Margin46.30%
Analyst Forecast
The average price target for Chugai Pharmaceutical Co is $8,900.49, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$8,900.49
Price Target Upside16.26% Upside
Analyst ConsensusModerate Buy
Analyst Count4
Revenue Growth Forecast17.96%
EPS Growth Forecast25.65%